Objective: Replication-deficient, recombinant adenovirus is used as a carrier for gene transfer, but it is unspecific and the onset of transgene expression is relatively late. Here, we evaluated the efficiency and selectivity of gene transfer mediated by recombinant Semliki Ž . Forest virus SFV . Methods: We compared the efficiency of a SFV-based vector with an adenoviral vector, using LacZ as a reporter gene. Firstly, the affinity for vascular smooth muscle cells, endothelial cells and cardiac myocytes was assessed. Secondly, we compared the time course of LacZ expression and cytotoxicity in vascular smooth muscle cells. Results: The SFV-based vector infects vascular smooth muscle cells and cardiomyocytes as efficiently as adenovirus. In contrast to adenovirus, SFV hardly transfers LacZ to endothelial Ž . cells 2.6% or less . SFV-mediated expression was visible after 1 h, reaching a maximum after 6 h. In contrast, adenovirus-mediated expression became visible after 6 h, and reached a maximum after 48-72 h. Both vectors were cytotoxic. Conclusions: We demonstrate that SFV efficiently transfers LacZ to vascular smooth muscle cells and cardiomyocytes, but not to endothelial cells. In contrast, adenovirus causes efficient transgene expression in all cell types tested. Furthermore, SFV-mediated expression is faster than adenovirus-mediated expression. Therefore, SFV-mediated gene transfer may be a suitable alternative to adenovirus, providing a fast expression in non-endothelial cardiovascular cell types. q 1997 Elsevier Science B.V.
Introduction
Somatic gene transfer is currently being evaluated as a treatment modality for various diseases. In cardiovascular disorders, viral gene transfer methods are most often targeted to inhibit restenosis after balloon angioplasty and w x atherosclerotic plaque formation 1 . Several viral vectors have been shown to be able to reduce smooth muscle w x proliferation both in vitro and in vivo 2 . We suggest that an efficient approach to gene therapy of restenosis should be based on a viral vector that specifically infects smooth muscle cells and that expresses its genes early. In this study, we have evaluated a vector Ž . based on the Semliki Forest virus SFV replicon, carrying Ž . the Escherichia coli LacZ gene pSFV3-LacZ . The genome of SFV consists of a positive RNA strand which can be translated directly after infection of the host cell. The immediately formed, non-structural, proteins include an RNA replicase, which mediates production of a high amount of total genomic and subgenomic RNA copies. As the subgenomic copies code for the structural proteins of SFV, new, infectious virus particles will be rapidly formed w x 3,4 . In pSFV3-LacZ the region coding for the structural viral proteins is replaced with the LacZ gene. Therefore, pSFV3-LacZ is a highly efficient, replication-deficient vector with a known rapid maximal expression of the bw x galactosidase reporter enzyme 3 .
pSFV3-LacZ is produced by co-transfection of RNA derived from recombinant vector with a helper RNA enw x coding the structural proteins 3 . Two packaging vectors w x called Helper1 and Helper2 have been designed 5 . Helper1-based virus stocks are directly active but may contain some wild-type virus which can cause infection in w x the host 5 . Helper2-based virus stocks have to be activated in vitro with chymotrypsin and contain hardly any w x active wild-type virus so that host infection is avoided 5 .
Gene transfer with Helper1-and Helper2-based pSFV3-LacZ was compared to gene transfer with an estab-Ž . lished vector based on adenovirus Ad5LacZ with respect Ž . to affinity for vascular smooth muscle cells VSMC and Ž . endothelial cells EC . Additionally, the timing of expression of Helper1-based vector and the cytotoxicity of Helper2-based vector were compared to Ad5LacZ in VSMC. Finally, pSFV3-LacZ-mediated gene transfer in rat cardiomyocytes was assessed. 
Methods

Isolation and culture of Õascular smooth muscle cells
Isolation and culture of cardiac myocytes
Ž . Cardiac myocytes rCM were isolated from neonatal w x rats and cultured as described elsewhere 10 on collagen-Ž . coated plastic slides Nunc . After 48 h, the cells were rinsed with serum free medium and exposed to virus.
Virus production
Ad5LacZ viral stocks were produced and quantified Ž using HEK 293 cells Microbix Biosystems Inc., Toronto, . Canada . The stock solution was determined to contain 10 pfu P ml y1 . pSFV3-LacZ was produced using pSFVHelper1, to obtain pSFV3-LacZrh1, or Helper2, to obtain pSFV3-LacZrh2, and quantified using BHK21 cells as w x 7 8 described previously 3 . Titers were between 10 and 10 infectious units per ml. In all cases, the virus stocks that were used originated from the same virus batch.
Efficiency and timing of expression of pSFV3-LacZr h1 and Ad5LacZ
Ž . 24-wells clusters Nunc, Roskilde, Denmark were seeded with 25.000 VSMC or 50.000 EC per well. VSMC and EC were allowed to regain morphology for 24 and 48 h, respectively. After this, the growth medium was taken off, the cells were washed with 1 = phosphate buffered Ž . Ž . saline PBS Biochrom and the virus was added, as described below. The virus was allowed to bind for 1 h, unless indicated otherwise. After this, the cells were washed with PBS and growth medium was added. In every experiment, negative controls were included, i.e. cells that were not exposed to the virus but to serum-free medium.
In order to estimate the number of infectious units, Ž
10
. dilution ranges 10-10 fold dilutions of virus stocks were prepared using serum-free DMEM. 200 ml of virus dilutions were added to separate wells containing VSMC Ž . Ž both pSFV3-LacZrh1 and Ad5LacZ and EC pSFV3-. LacZrh1 . After binding of the virus, the cells were Ž . Ž . cultured for 24 h pSFV-LacZ or 72 h Ad5LacZ .
pSFV was compared to Ad5LacZ in subconfluent cultures of EA.hy 926 cells in a six-wells cluster, using 400 ml of each virus stock per well and allowing 48 h of viral gene expression, at 378C, 5% CO . During viral gene 2 expression, cells were kept in growth medium.
To estimate the time course of pSFV3-LacZrh1 and Ad5LacZ expression, 12.500 A7r5 cells P well y1 were seeded in 48-wells clusters. 200 ml of virus dilution was added per well. After incubation with the virus, the cells were cultured for 1, 3, 6, 12, 24, 48 and 72 h, respectively. The procedures were repeated in a separate experiment for HA-VSMC.
To investigate the possibility of gene transfer to cardiovascular cells other than VSMC, neonatal cardiac myocytes were cultured. These cardiac myocytes were incubated with 50 ml of pSFV3-LacZrh1 stock solution. After 14 h, 200 ml of growth medium was added, and 22 h after addition of the virus, cells were fixed and analysed as described below.
Efficiency and cytotoxicity of pSFV3-LacZr h2 and Ad5LacZ
A7r5 and HUVEC were seeded in 24-wells clusters and treated with virus as described above. At 1, 2, 3, 6 and 12 days after exposure to the virus, the culture medium was collected, the cells were detached from the wells by trypsinisation and resuspended in the collected medium. At each time point, the number of viable cells was counted in suspensions obtained from one well per treatment by Trypan Blue exclusion in a Burker counting chamber. Thus, Ž . each value represents the mean "SEM obtained from 6 samples from one well. Additionally, the effect of pSFV3-LacZrh2 on survival of HUVECs after 12 days was assessed. Furthermore, affinity of pSFV3-LacZrh2 and Ad5LacZ for A7r5 and HUVEC were compared.
Histological procedures
After the expression times indicated above, the cells were washed with PBS and fixed with 1,25% glutaric Ž . aldehyde Sigma for 5 min at room temperature. Thereafter, the cells were washed with PBS and incubated with X-Gal staining fluid for 1-4 h at 378C. X-Gal staining fluid contained 1 mg P ml Ž . Sigma . Finally, the cells were washed with PBS, postfixed with 1,25% glutaric aldehyde for 2 min and either Ž analysed immediately or stored under 90% glycerol Jansse, . Beersse, Belgium until analysis.
Comparison of Õirus titers and efficiency of gene transfer
To quantify the efficiency of gene transfer, the percentage of LacZ-positive cells was determined. After the staining procedure, treated and controled cultures were analysed in situ under a light microscope at random locations Ž . magnifications: 63 = and 200 = . If necessary, photographs were taken from random locations within the separate wells and used for analysis. Each value represents Ž . the mean "SEM of five random samples in a single well. Data from a single experiment that were obtained from both direct observation under a light microscope and Ž . photographical analysis were similar data not shown .
To estimate virus titers, the dilution step just before the one resulting in no LacZ expression was used. The number of positive cells in the wells which received this virus dilution were counted. The titers were calculated as N P p Ž 1rDFP 5 and expressed in infectious units per ml IU P y1 . ml , where N s number of positive cells, DF s dilution p factor. One IU corresponds to the amount of virus capable of transferring LacZ to a single cell.
Statistical procedures
All means were compared with t-tests for independent samples. Standard errors of the means are indicated in the graphs with error bars. The viability curves for A7r5 were analysed and compared with ANOVA for repeated measures. Table 1 
Results
Efficiency of Õiral gene transfer into Õascular smooth muscle cells
Efficiency of Õiral gene transfer into endothelial cells
The number of LacZ-positive BAEC, ECV 304 and EA.hy 926 cells after gene transfer with pSFV3-LacZrh1 never exceeded 2.6%, while HA-VSMC, as a positive control, always showed a high efficiency of gene transfer HA-VSMC 2=10 IUPml Ž . Fig. 2 . This is also reflected by the titration experiment shown in Table 2 . As it is known that a small percentage Ž of primary cultured BAEC are of other origin e.g. smooth . muscle cells or fibroblasts , this could result in a higher titer for BAEC as compared to the other EC. Still, the maximal percentage of positive BAEC is not higher than that of EA.hy 926. In a separate experiment EC-RF24 was Ž . tested yielding similar results Fig. 2 . In contrast to pSFV3-LacZrh1, Ad5LacZ transferred LacZ into EA.hy Ž 926 with moderate efficiency pSFV3-LacZrh1, 1.1% " . Ž . 0.2 vs. Ad5LacZ, 16.7% " 3.1. p s 0.007 Fig. 3 . Comparison of pSFV3-LacZrh2 with Ad5lacZ in HUVEC Ž resulted in a similar observation 1.0% " 0.4 vs. 33.6% " . 8.3 . Medium-treated endothelial cells were negative. 
Gene transfer into cardiac myocytes
The amount of LacZ-positive cardiac myocytes after gene transfer with pSFV3-LacZrh1 was 79% " 1. The morphology of positive myocytes after 22 h of expression Ž . showed that cells were intact results not shown .
Time course of Õiral expression
Ž
. In a time course experiment with A7r5 Fig. 4 , the first positive cells were seen 1 h after incubation with pSFV-Ž . LacZrh1 31% and 6 h after incubation with Ad5LacZ Ž . -1% . In addition, there was an increasing intensity of LacZ staining in time. At each time point, the differences between efficiency of gene transfer by pSFV3-LacZrh1 Ž . and Ad5LacZ were significant p F 0.05 . Medium-treated cultures were negative.
In HA-VSMC, initial LacZ expression was seen after 6 Ž . h for pSFV3-LacZrh1 22.5% " 7.8 and after 12 h for Ž . Ad5LacZ 34.0% " 5.6 . Maximal efficiency was reached Ž . after 24 h for pSFV3-LacZrh1 78.4% " 6.8 and 48 h for Ž . Ad5LacZ 54.5% " 5.2 . Due to low background staining that occured after long exposure of HA-VSMC to LacZ staining solution at 1 h and 3 h, low expression could be masked. Therefore, we cannot exclude expression earlier than 6 h for pSFV3-LacZ and 12 h for Ad5LacZ.
Cytotoxicity of pSFV3-LacZr h2 and Ad5LacZ
The effect of pSFV3-LacZrh2 and Ad5LacZ on growth of A7r5 is shown in Fig. 5 . Both viruses cause cell death and after 12 days the amount of A7r5 was too low to be counted. In HUVEC, however, the number of cells was not Ž decreased 12 days after exposure to pSFV3-LacZrh2 3.6 P 10
4 " 3739 cells P well y1 at day 0 vs. 5.7 P 10 4 " 3867 y1
. Ž 4 cells P well at day 12 or vehicle 4.4 P 10 " 2656 cells P well y1 at day 0 vs. 4.6 P 10 4 " 4110 cells P well y1 at day . 12 . The percentage transfection efficiency reached in A7r5 was higher than 80%. However, we observed that A7r5 surviving the period of 12 days were not expressing LacZ.
Discussion
In the present study we compared recombinant SFV to adenovirus with respect to its use for gene transfer into cultured cardiovascular cells. The results show that SFV efficiently transfers LacZ to VSMC and rCM. In contrast to Ad5LacZ, pSFV3-LacZ does not cause efficient gene transfer into EC. Therefore, pSFV3-LacZ can be considered as a vector with relative specificity for non-endothelial cells. Sensitivity of both EC and VSMC for adenoviral vectors in vitro and in vivo has been described w x extensively by others 11-13 and confirmed in the present study. Selective adenovirus-mediated gene transfer to EC w x has been shown to be feasible 14 .
We show here that both pSFV3-LacZ and Ad5LacZ are cytotoxic to VSMC, whereas HUVEC survive exposure to pSFV3-LacZ. pSFV3-LacZ will cause inhibition of target cell protein synthesis, ultimately leading to apoptosis of w x the transfected cells 4,15 . Recently, it has been shown that overexpression of the proto-oncogene bcl-2 allowed survival of rat prostatic adenocarcinoma cells after expow x sure to SFV 16 . Others have already shown that Ad5LacZ w x w x is cytotoxic to both EC 14 and VSMC 17 in vivo. It remains unknown what causes the insensitivity of endothelial cells for pSFV3-LacZ. Further studies with EC should address bcl-2 expression but also virus binding, internalization and disassembly of virus particles, and RNA translation.
The properties of SFV to transfer genes rapidly and efficiently into non-endothelial cells could be important for treatment of vascular lesions in which the endothelium has to be spared and where VSMC are the specific target, e.g. after balloon injury and in atherosclerotic plaques. Furthermore, it would be particularly suitable to block early gene expression, thereby preventing a cascade of molecular processes that lead to deleterious processes such as Ž . re stenosis. The proto-oncogene c-myc could represent a possible target, since expression of c-myc reaches its peak w x as early as 2 h after balloon injury 18 .
Toxicity of a gene-therapy vector can become evident at the level of the entire organism. Production of recombinant SFV with pSFV-Helper1 will result in the formation of Ž . low amounts of replication-proficiant virus RPV which w x might cause an infection 5 . Therefore, a packaging vector Ž . called pSFV-Helper2 helper 2 has been designed to w x produce particles with a mutated p62 spike protein 5 . The wild-type p62 is normally cleaved into its active, mature form E2 by a host endoprotease. Mutant p62, however, cannot be cleaved in vivo and has to be converted in E2 in vitro by chymotrypsin. Thus, conditionally infectious recombinant particles can be produced that do not contain RPV and do not cause pathological effects nor result in ( )w x immunity in BALBrc mice 5 . Therefore, helper 2-based recombinant SFV may be a suitable vector for in vivo gene transfer into VSMC. pSFV3 recombinant particles have been used in vivo for induction of cytotoxic T lymphocyte w x activity against the influenza nucleoprotein 19 .
Vectors derived from DNA viruses, such as adenovirus, could incorporate into the host genome, hypothetically leading to a life-long expression of the introduced gene. This is not the case with SFV, as this is a positive-strand RNA virus that replicates in the cytoplasm. We found that those cells that did survive exposure to Ad5LacZ were not expressing LacZ after 12 days of culture. Therefore, expression of LacZ in vivo long after exposure to adenovirus may actually represent cells that start expressing Ad5LacZ relatively late. In this case, loss of transgene expression can be caused by exhaustion of transfected cells through cell death. As SFV expresses its genes more rapidly than adenovirus, it can be expected that SFV-mediated expression will last shorter.
We demonstrate that the SFV vector provides a more rapid and more selective gene transfer than adenovirus, at comparable cytotoxicity levels. Obviously, these in vitro data await further elaboration in vivo. 
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